Posted on: Jan. 18, 2018, 8:01 a.m.
Celgene Eyes Juno Therapeutics Celegene Corporation is in discussions to buy Seattle-based Juno Therapeutics. Juno Therapeutics has backers which include the Alaska Permanent Fund Corporation (APFC). Celgene has roughly US$ 12 billion in cash and already has a relationship with Juno Therapeutics. Auckland International Airport Sells Down Airport Holdings in NQA and Cairns Perron Investments […] Full investment news article